VEE crypto, the native token of the SmartNFT analytics platform BLOCKv, soared by 100% in 7 days. In doing so, it ...

A rapid heartbeat and shortness of breath could be signs of atrial fibrillation (AFib), an irregular heartbeat. Dr. Jim Stone, a cardiac electrophysiologist at North Medical Center in Tupelo, helps ...

Novartis has announced that it will be expanding its late-stage cardiovascular pipeline by acquiring Anthos Therapeutics for ...

In patients with symptoms such as irregular heartbeats, dizziness, or fainting, or in individuals that physicians suspect may ...

About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

Smartphones are useful tools for everyday life but they’re privy to nearly everything about you, including all the places you ...

Novartis to buy Boston-based clinical-stage biopharma company, Anthos Therapeutics for up to $3.1 billion: Basel Tuesday, February 11, 2025, 17:45 Hrs [IST] Novartis announced tha ...

Anthos is currently conducting a phase 3 clinical study in patients with atrial fibrillation with high risk for stroke or systemic embolism (LILAC-TIMI 76) as well as two phase 3 studies in patients ...

Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is currently in P ...

The Watchman device is providing protection from blood clots and strokes for those patients at risk because of their AFib.

Abelacimab is a fully human monoclonal antibody that binds to the inactive form of factor XI and blocks its activation ... in patients with atrial fibrillation is unknown. Patients with atrial ...

Flossing at least once a week can significantly lower the risk of various types of stroke, including ischemic stroke, ...